| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.8 |